PHASE 2 STUDY
Clinical trials for PHASE 2 STUDY explained in plain language.
Never miss a new study
Get alerted when new PHASE 2 STUDY trials appear
Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis study tests whether adding the drug BMS-986504 to standard chemotherapy can help control pancreatic cancer in people with a specific genetic change (MTAP deletion). About 60 adults with this type of pancreatic cancer will receive the combination before and after surgery or w…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for aggressive lymphoma: drug cocktail aims to control High-Risk MCL
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug glofitamab after an initial treatment with acalabrutinib (or zanubrutinib) and rituximab can better control high-risk mantle cell lymphoma (MCL) in people who have not been treated before. The study will enroll 30 participants…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC